Dr Martens PLC
LSE:DOCS
Intrinsic Value
Dr. Martens Plc engages in the manufacture and sale of footwear products. [ Read More ]
The intrinsic value of one DOCS stock under the Base Case scenario is 183.87 GBX. Compared to the current market price of 72.65 GBX, Dr Martens PLC is Undervalued by 60%.
Valuation Backtest
Dr Martens PLC
Run backtest to discover the historical profit from buying and selling DOCS stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Dr Martens PLC
Current Assets | 491.5m |
Cash & Short-Term Investments | 45.7m |
Receivables | 130.3m |
Other Current Assets | 315.5m |
Non-Current Assets | 536.9m |
Long-Term Investments | 1m |
PP&E | 259.4m |
Intangibles | 265.5m |
Other Non-Current Assets | 11m |
Current Liabilities | 201.4m |
Accounts Payable | 124.8m |
Other Current Liabilities | 76.6m |
Non-Current Liabilities | 463.4m |
Long-Term Debt | 456.7m |
Other Non-Current Liabilities | 6.7m |
Earnings Waterfall
Dr Martens PLC
Revenue
|
977.5m
GBP
|
Cost of Revenue
|
-362.3m
GBP
|
Gross Profit
|
615.2m
GBP
|
Operating Expenses
|
-454.1m
GBP
|
Operating Income
|
161.1m
GBP
|
Other Expenses
|
-57.9m
GBP
|
Net Income
|
103.2m
GBP
|
Free Cash Flow Analysis
Dr Martens PLC
DOCS Profitability Score
Profitability Due Diligence
Dr Martens PLC's profitability score is 67/100. The higher the profitability score, the more profitable the company is.
Score
Dr Martens PLC's profitability score is 67/100. The higher the profitability score, the more profitable the company is.
DOCS Solvency Score
Solvency Due Diligence
Dr Martens PLC's solvency score is 49/100. The higher the solvency score, the more solvent the company is.
Score
Dr Martens PLC's solvency score is 49/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
DOCS Price Targets Summary
Dr Martens PLC
According to Wall Street analysts, the average 1-year price target for DOCS is 97.69 GBX with a low forecast of 85.85 GBX and a high forecast of 115.5 GBX.
Shareholder Return
DOCS Price
Dr Martens PLC
Average Annual Return | -29% |
Standard Deviation of Annual Returns | 34.66% |
Max Drawdown | -87% |
Market Capitalization | 705.3m GBX |
Shares Outstanding | 1 002 000 000 |
Percentage of Shares Shorted | 151% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Dr. Martens Plc engages in the manufacture and sale of footwear products. The firm operates through three reporting segments: Europe, the Middle East and Africa (EMEA), Americas and Americas and Asia-Pacific (APAC). Its product categories include Originals, Fusion, Kids, Casual and Accessories. The Originals category comprises boots, shoes and loafers and also included within the Originals category is the Made in England range. The Fusion category comprises platform boots and shoes, sandals, heels and refined take downs of the Originals. Within the Kids category is the mini-me range, which includes Originals, Fusion and Casual collections. The company offers various accessories, such as shoe care, laces and socks, leather bags and small leather items. The company operates in over 60 countries globally, through a range of modes: directly operated stores and ecommerce sites, wholesale partners and distributors.
Contact
IPO
Employees
Officers
The intrinsic value of one DOCS stock under the Base Case scenario is 183.87 GBX.
Compared to the current market price of 72.65 GBX, Dr Martens PLC is Undervalued by 60%.